Cargando…

A 33-mRNA Classifier Is Able to Produce Inflammopathic, Adaptive, and Coagulopathic Endotypes with Prognostic Significance: The Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis (ORANGES) Trial

Background: Retrospective analysis of the transcriptomic host response in sepsis has demonstrated that sepsis can be separated into three endotypes—inflammatory (IE), adaptive (AE), and coagulopathic (CE), which have demonstrated prognostic significance. We undertook a prospective transcriptomic hos...

Descripción completa

Detalles Bibliográficos
Autores principales: Iglesias, Jose, Vassallo, Andrew V., Liesenfeld, Oliver, Levine, Jerrold S., Patel, Vishal V., Sullivan, Jesse B., Cavanaugh, Joseph B., Elbaga, Yasmine, Sweeney, Timothy E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822486/
https://www.ncbi.nlm.nih.gov/pubmed/33374697
http://dx.doi.org/10.3390/jpm11010009
_version_ 1783639647656607744
author Iglesias, Jose
Vassallo, Andrew V.
Liesenfeld, Oliver
Levine, Jerrold S.
Patel, Vishal V.
Sullivan, Jesse B.
Cavanaugh, Joseph B.
Elbaga, Yasmine
Sweeney, Timothy E.
author_facet Iglesias, Jose
Vassallo, Andrew V.
Liesenfeld, Oliver
Levine, Jerrold S.
Patel, Vishal V.
Sullivan, Jesse B.
Cavanaugh, Joseph B.
Elbaga, Yasmine
Sweeney, Timothy E.
author_sort Iglesias, Jose
collection PubMed
description Background: Retrospective analysis of the transcriptomic host response in sepsis has demonstrated that sepsis can be separated into three endotypes—inflammatory (IE), adaptive (AE), and coagulopathic (CE), which have demonstrated prognostic significance. We undertook a prospective transcriptomic host response analysis in a subgroup of patients enrolled in the Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis (ORANGES) trial. Methods: Blood was obtained from 51 patients and profiled using a pre-established 33-mRNA classifier to determine sepsis endotypes. Endotypes were compared to therapy subgroups and clinical outcomes. Results: We redemonstrated a statistically significant difference in mortality between IE, AE, and CE patients, with CE patients demonstrating the highest mortality (40%), and AE patients the lowest mortality (5%, p = 0.032). A higher CE score was a predictor of mortality; coronary artery disease (CAD) and elevated CE scores were associated with an increase in mortality (CAD: HR = 12.3, 95% CI 1.5–101; CE score: HR = 15.5 95% CI 1.15–211). Kaplan–Meier (KM) analysis of the entire cohort (n = 51) demonstrated a decrease survival in the CE group, p = 0.026. KM survival analysis of hydrocortisone, ascorbic acid, and thiamine (HAT) therapy and control patients not receiving steroids (n = 45) showed CE and IE was associated with a decrease in survival (p = 0.003); of interest, there was no difference in survival in CE patients after stratifying by HAT therapy (p = 0.18). These findings suggest a possible treatment effect of corticosteroids, HAT therapy, endotype, and outcome. Conclusion: This subset of patients from the ORANGES trial confirmed previous retrospective findings that a 33-mRNA classifier can group patients into IE, AE, and CE endotypes having prognostic significance. A novel finding of this study identifying an association between endotype and corticosteroid therapy warrants further study in support of future diagnostic use of the endotyping classifier.
format Online
Article
Text
id pubmed-7822486
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78224862021-01-23 A 33-mRNA Classifier Is Able to Produce Inflammopathic, Adaptive, and Coagulopathic Endotypes with Prognostic Significance: The Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis (ORANGES) Trial Iglesias, Jose Vassallo, Andrew V. Liesenfeld, Oliver Levine, Jerrold S. Patel, Vishal V. Sullivan, Jesse B. Cavanaugh, Joseph B. Elbaga, Yasmine Sweeney, Timothy E. J Pers Med Article Background: Retrospective analysis of the transcriptomic host response in sepsis has demonstrated that sepsis can be separated into three endotypes—inflammatory (IE), adaptive (AE), and coagulopathic (CE), which have demonstrated prognostic significance. We undertook a prospective transcriptomic host response analysis in a subgroup of patients enrolled in the Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis (ORANGES) trial. Methods: Blood was obtained from 51 patients and profiled using a pre-established 33-mRNA classifier to determine sepsis endotypes. Endotypes were compared to therapy subgroups and clinical outcomes. Results: We redemonstrated a statistically significant difference in mortality between IE, AE, and CE patients, with CE patients demonstrating the highest mortality (40%), and AE patients the lowest mortality (5%, p = 0.032). A higher CE score was a predictor of mortality; coronary artery disease (CAD) and elevated CE scores were associated with an increase in mortality (CAD: HR = 12.3, 95% CI 1.5–101; CE score: HR = 15.5 95% CI 1.15–211). Kaplan–Meier (KM) analysis of the entire cohort (n = 51) demonstrated a decrease survival in the CE group, p = 0.026. KM survival analysis of hydrocortisone, ascorbic acid, and thiamine (HAT) therapy and control patients not receiving steroids (n = 45) showed CE and IE was associated with a decrease in survival (p = 0.003); of interest, there was no difference in survival in CE patients after stratifying by HAT therapy (p = 0.18). These findings suggest a possible treatment effect of corticosteroids, HAT therapy, endotype, and outcome. Conclusion: This subset of patients from the ORANGES trial confirmed previous retrospective findings that a 33-mRNA classifier can group patients into IE, AE, and CE endotypes having prognostic significance. A novel finding of this study identifying an association between endotype and corticosteroid therapy warrants further study in support of future diagnostic use of the endotyping classifier. MDPI 2020-12-23 /pmc/articles/PMC7822486/ /pubmed/33374697 http://dx.doi.org/10.3390/jpm11010009 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Iglesias, Jose
Vassallo, Andrew V.
Liesenfeld, Oliver
Levine, Jerrold S.
Patel, Vishal V.
Sullivan, Jesse B.
Cavanaugh, Joseph B.
Elbaga, Yasmine
Sweeney, Timothy E.
A 33-mRNA Classifier Is Able to Produce Inflammopathic, Adaptive, and Coagulopathic Endotypes with Prognostic Significance: The Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis (ORANGES) Trial
title A 33-mRNA Classifier Is Able to Produce Inflammopathic, Adaptive, and Coagulopathic Endotypes with Prognostic Significance: The Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis (ORANGES) Trial
title_full A 33-mRNA Classifier Is Able to Produce Inflammopathic, Adaptive, and Coagulopathic Endotypes with Prognostic Significance: The Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis (ORANGES) Trial
title_fullStr A 33-mRNA Classifier Is Able to Produce Inflammopathic, Adaptive, and Coagulopathic Endotypes with Prognostic Significance: The Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis (ORANGES) Trial
title_full_unstemmed A 33-mRNA Classifier Is Able to Produce Inflammopathic, Adaptive, and Coagulopathic Endotypes with Prognostic Significance: The Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis (ORANGES) Trial
title_short A 33-mRNA Classifier Is Able to Produce Inflammopathic, Adaptive, and Coagulopathic Endotypes with Prognostic Significance: The Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis (ORANGES) Trial
title_sort 33-mrna classifier is able to produce inflammopathic, adaptive, and coagulopathic endotypes with prognostic significance: the outcomes of metabolic resuscitation using ascorbic acid, thiamine, and glucocorticoids in the early treatment of sepsis (oranges) trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822486/
https://www.ncbi.nlm.nih.gov/pubmed/33374697
http://dx.doi.org/10.3390/jpm11010009
work_keys_str_mv AT iglesiasjose a33mrnaclassifierisabletoproduceinflammopathicadaptiveandcoagulopathicendotypeswithprognosticsignificancetheoutcomesofmetabolicresuscitationusingascorbicacidthiamineandglucocorticoidsintheearlytreatmentofsepsisorangestrial
AT vassalloandrewv a33mrnaclassifierisabletoproduceinflammopathicadaptiveandcoagulopathicendotypeswithprognosticsignificancetheoutcomesofmetabolicresuscitationusingascorbicacidthiamineandglucocorticoidsintheearlytreatmentofsepsisorangestrial
AT liesenfeldoliver a33mrnaclassifierisabletoproduceinflammopathicadaptiveandcoagulopathicendotypeswithprognosticsignificancetheoutcomesofmetabolicresuscitationusingascorbicacidthiamineandglucocorticoidsintheearlytreatmentofsepsisorangestrial
AT levinejerrolds a33mrnaclassifierisabletoproduceinflammopathicadaptiveandcoagulopathicendotypeswithprognosticsignificancetheoutcomesofmetabolicresuscitationusingascorbicacidthiamineandglucocorticoidsintheearlytreatmentofsepsisorangestrial
AT patelvishalv a33mrnaclassifierisabletoproduceinflammopathicadaptiveandcoagulopathicendotypeswithprognosticsignificancetheoutcomesofmetabolicresuscitationusingascorbicacidthiamineandglucocorticoidsintheearlytreatmentofsepsisorangestrial
AT sullivanjesseb a33mrnaclassifierisabletoproduceinflammopathicadaptiveandcoagulopathicendotypeswithprognosticsignificancetheoutcomesofmetabolicresuscitationusingascorbicacidthiamineandglucocorticoidsintheearlytreatmentofsepsisorangestrial
AT cavanaughjosephb a33mrnaclassifierisabletoproduceinflammopathicadaptiveandcoagulopathicendotypeswithprognosticsignificancetheoutcomesofmetabolicresuscitationusingascorbicacidthiamineandglucocorticoidsintheearlytreatmentofsepsisorangestrial
AT elbagayasmine a33mrnaclassifierisabletoproduceinflammopathicadaptiveandcoagulopathicendotypeswithprognosticsignificancetheoutcomesofmetabolicresuscitationusingascorbicacidthiamineandglucocorticoidsintheearlytreatmentofsepsisorangestrial
AT sweeneytimothye a33mrnaclassifierisabletoproduceinflammopathicadaptiveandcoagulopathicendotypeswithprognosticsignificancetheoutcomesofmetabolicresuscitationusingascorbicacidthiamineandglucocorticoidsintheearlytreatmentofsepsisorangestrial
AT iglesiasjose 33mrnaclassifierisabletoproduceinflammopathicadaptiveandcoagulopathicendotypeswithprognosticsignificancetheoutcomesofmetabolicresuscitationusingascorbicacidthiamineandglucocorticoidsintheearlytreatmentofsepsisorangestrial
AT vassalloandrewv 33mrnaclassifierisabletoproduceinflammopathicadaptiveandcoagulopathicendotypeswithprognosticsignificancetheoutcomesofmetabolicresuscitationusingascorbicacidthiamineandglucocorticoidsintheearlytreatmentofsepsisorangestrial
AT liesenfeldoliver 33mrnaclassifierisabletoproduceinflammopathicadaptiveandcoagulopathicendotypeswithprognosticsignificancetheoutcomesofmetabolicresuscitationusingascorbicacidthiamineandglucocorticoidsintheearlytreatmentofsepsisorangestrial
AT levinejerrolds 33mrnaclassifierisabletoproduceinflammopathicadaptiveandcoagulopathicendotypeswithprognosticsignificancetheoutcomesofmetabolicresuscitationusingascorbicacidthiamineandglucocorticoidsintheearlytreatmentofsepsisorangestrial
AT patelvishalv 33mrnaclassifierisabletoproduceinflammopathicadaptiveandcoagulopathicendotypeswithprognosticsignificancetheoutcomesofmetabolicresuscitationusingascorbicacidthiamineandglucocorticoidsintheearlytreatmentofsepsisorangestrial
AT sullivanjesseb 33mrnaclassifierisabletoproduceinflammopathicadaptiveandcoagulopathicendotypeswithprognosticsignificancetheoutcomesofmetabolicresuscitationusingascorbicacidthiamineandglucocorticoidsintheearlytreatmentofsepsisorangestrial
AT cavanaughjosephb 33mrnaclassifierisabletoproduceinflammopathicadaptiveandcoagulopathicendotypeswithprognosticsignificancetheoutcomesofmetabolicresuscitationusingascorbicacidthiamineandglucocorticoidsintheearlytreatmentofsepsisorangestrial
AT elbagayasmine 33mrnaclassifierisabletoproduceinflammopathicadaptiveandcoagulopathicendotypeswithprognosticsignificancetheoutcomesofmetabolicresuscitationusingascorbicacidthiamineandglucocorticoidsintheearlytreatmentofsepsisorangestrial
AT sweeneytimothye 33mrnaclassifierisabletoproduceinflammopathicadaptiveandcoagulopathicendotypeswithprognosticsignificancetheoutcomesofmetabolicresuscitationusingascorbicacidthiamineandglucocorticoidsintheearlytreatmentofsepsisorangestrial